This assay measures reduced, free oxidized, protein-bound, and total homocysteine in human plasma. Oxidized species of homocysteine are converted to reduced form by sodium borohydride, and, after precolumn derivatization with 2-chloro-1-methylquinolinium tetrafluoroborate, homocysteine 2-S-quinolinium derivative is separated from those of other plasma thiol derivatives, and quantitated by ion-paired reversed-phase high-performance liquid chromatography with ultraviolet detection. The reduced homocysteine sulfhydryl groups are trapped with minimal oxidation by derivatizing blood samples at the time of collection. With the use of this precise and sensitive HPLC method utilizing popular ultraviolet detection, homocysteine in plasma can be detected and quantitated at the level of 0.1 and 0.2 for reduced fraction, and 0.3 and 0.5 nmol/ml for total homocysteine, respectively. The method is applied for determination of different fractions of homocysteine in plasma of apparently healthy men and women.